Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Monserrat

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
JAMA Cardiology|March 30, 2022
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-BlockersAndrea Mazzanti, Deni Kukavica, Alessandro Trancuccio, et al.
European Journal of Medical Genetics|October 9, 2020
The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individualsJoel Salazar-Mendiguchía, Roberto Barriales-Villa, Luis R Lopes, et al.
ACS Nano|June 1, 2021
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic CardiomyopathyCarmen Suay-Corredera, Maria Rosaria Pricolo, Diana Velázquez-Carreras, et al.
European Journal of Heart Failure|September 25, 2025
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESCMarta Gigli, Job A J Verdonschot, Pablo Garcia-Pavia, et al.
The Journal of Biological Chemistry|June 7, 2021
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathyCarmen Suay-Corredera, Maria Rosaria Pricolo, Elías Herrero-Galán, et al.
Heart (British Cardiac Society)|October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysisConstantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
European Heart Journal|September 3, 2025
Clinical care of family members of patients with dilated cardiomyopathyJob A J Verdonschot, Juan Pablo Kaski, Folkert W Asselbergs, et al.
Nature Medicine|January 15, 2013
Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathyGuillermo Luxán, Jesús C Casanova, Beatriz Martínez-Poveda, et al.
Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.
International Journal of Cardiology|October 16, 2023
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus reportDomenico Corrado, Aris Anastasakis, Cristina Basso, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
JAMA Cardiology|March 30, 2022
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-BlockersAndrea Mazzanti, Deni Kukavica, Alessandro Trancuccio, et al.
European Journal of Medical Genetics|October 9, 2020
The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individualsJoel Salazar-Mendiguchía, Roberto Barriales-Villa, Luis R Lopes, et al.
ACS Nano|June 1, 2021
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic CardiomyopathyCarmen Suay-Corredera, Maria Rosaria Pricolo, Diana Velázquez-Carreras, et al.
European Journal of Heart Failure|September 25, 2025
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESCMarta Gigli, Job A J Verdonschot, Pablo Garcia-Pavia, et al.
The Journal of Biological Chemistry|June 7, 2021
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathyCarmen Suay-Corredera, Maria Rosaria Pricolo, Elías Herrero-Galán, et al.
Heart (British Cardiac Society)|October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysisConstantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
European Heart Journal|September 3, 2025
Clinical care of family members of patients with dilated cardiomyopathyJob A J Verdonschot, Juan Pablo Kaski, Folkert W Asselbergs, et al.
Nature Medicine|January 15, 2013
Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathyGuillermo Luxán, Jesús C Casanova, Beatriz Martínez-Poveda, et al.
Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.
International Journal of Cardiology|October 16, 2023
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus reportDomenico Corrado, Aris Anastasakis, Cristina Basso, et al.
Pageof 16